Business Description
Therapeutic Solutions International Inc
NAICS : 325412
SIC : 2834
ISIN : US8833781011
Description
Therapeutic Solutions International Inc focuses on immune modulation for the treatment of several specific diseases. It is engaged in developing a range of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. The business divisions of the company are Nutraceutical Division which produces nutraceuticals. Its current product, QuadraMune, is a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone. Cellular Division obtained exclusive rights to a patented adult stem cell for the development of therapeutics in the area of chronic traumatic encephalopathy and traumatic brain injury and Lung Pathology.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.34 | |||||
| Debt-to-Equity | 0.79 | |||||
| Debt-to-EBITDA | -0.6 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -10.19 | |||||
| Beneish M-Score | -4.35 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.96 | |||||
| 9-Day RSI | 32.26 | |||||
| 14-Day RSI | 37.03 | |||||
| 6-1 Month Momentum % | -42.86 | |||||
| 12-1 Month Momentum % | -77.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.05 | |||||
| Quick Ratio | 0.03 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 320.39 | |||||
| Days Sales Outstanding | 75.21 | |||||
| Days Payable | 3970.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.4 | |||||
| Shareholder Yield % | -22.39 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.64 | |||||
| Operating Margin % | -2007.07 | |||||
| Net Margin % | -2190.91 | |||||
| FCF Margin % | -1065.66 | |||||
| ROE % | -171.73 | |||||
| ROA % | -62.3 | |||||
| ROIC % | -45.28 | |||||
| ROC (Joel Greenblatt) % | -425.9 | |||||
| ROCE % | -126.41 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | N/A |
N/A
|
N/A
| |||
| PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
| EV-to-EBIT | -1.89 | |||||
| EV-to-EBITDA | -2.29 | |||||
| EV-to-Revenue | 34.32 | |||||
| EV-to-FCF | -3.62 | |||||
| Earnings Yield (Greenblatt) % | -52.91 | |||||
| FCF Yield % | -41.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:TSOI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Therapeutic Solutions International Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.099 | ||
| EPS (TTM) ($) | 0 | ||
| Beta | 0.24 | ||
| Volatility % | 61.2 | ||
| 14-Day RSI | 37.03 | ||
| 14-Day ATR ($) | 0.000151 | ||
| 20-Day SMA ($) | 0.000823 | ||
| 12-1 Month Momentum % | -77.4 | ||
| 52-Week Range ($) | 0.0005 - 0.0034 | ||
| Shares Outstanding (Mil) | 4,230.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Therapeutic Solutions International Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Therapeutic Solutions International Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Therapeutic Solutions International Inc Frequently Asked Questions
What is Therapeutic Solutions International Inc(TSOI)'s stock price today?
The current price of TSOI is $0.00. The 52 week high of TSOI is $0.00 and 52 week low is $0.00.
When is next earnings date of Therapeutic Solutions International Inc(TSOI)?
The next earnings date of Therapeutic Solutions International Inc(TSOI) is 2024-05-16 Est..
Does Therapeutic Solutions International Inc(TSOI) pay dividends? If so, how much?
Therapeutic Solutions International Inc(TSOI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers